Mankind Pharma

Market Cap: Large Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE634S01028
NSEID: MANKIND
BSEID: 543904

INR

2,142.90

-36.65 (-1.68%)

BSENSE

Dec 15

BSE+NSE Vol: 7.35 lacs

{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,142.90",
    "chg": -36.65,
    "chgp": "-1.68%",
    "dir": -1,
    "prev_price": "2,179.55",
    "mcapval": "89,050.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE634S01028",
    "curr_date": "Dec 15",
    "curr_time": "",
    "bse_nse_vol": "7.35 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 15, 2025",
    "traded_date_str": "2025 12 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mankind-pharma-1003845-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mankind Pharma Sees Revision in Market Assessment Amidst Valuation and Performance Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-downgraded-to-sell-by-marketsmojo-amidst-weak-financial-and-technical-trends-3756184",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MankindPharma_mojoScore_3756184.png",
        "date": "2025-12-11 10:10:16",
        "description": "Mankind Pharma's market evaluation has undergone a notable revision, reflecting shifts in its financial and technical outlook. The pharmaceutical company’s recent assessment highlights a complex interplay of valuation concerns, flat financial trends, and subdued technical indicators, set against a backdrop of underwhelming stock returns over the past year."
      },
      {
        "title": "Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-rise-amid-weak-price-momentum-3744453",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MankindPharma_oi_spurts_by_underlying_3744453.png",
        "date": "2025-12-03 15:00:12",
        "description": "Mankind Pharma has experienced a significant rise in open interest in its derivatives segment, signalling a shift in market positioning amid recent price movements and sector trends. This development comes as the stock trades close to its 52-week low, with volume and futures activity reflecting evolving investor sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Mankind Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mankind-pharma-technically-bullish-or-bearish-3740546",
        "imagepath": "",
        "date": "2025-12-02 09:14:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Price Action and Trend</strong></p>\n<p>Mankind Pharma’s share price currently stands at ₹2,235.40, slightly down from the previous close of ₹2,251.85. The stock has traded within a daily range of ₹2,224.70 to ₹2,271.95, reflecting modest intraday volatility. Over the past 52 weeks, the stock has seen a high of ₹3,050.00 and a low of ₹2,115.50, indicating a significant drawdown from its peak levels.</p>\n<p>The technical trend’s recent shift from mildly bearish to bearish signals a deterioration in momentum, suggesting that sellers are gaining control. This change is critical for traders and investors who rely on technical analysis to time their entries and exits.</p>\n<p><strong>Technical Indicators: Mixed but Leaning Bearish</strong></p>\n<p>Examining the key technical indi..."
      },
      {
        "title": "Mankind Pharma Technical Momentum Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-technical-momentum-shifts-amid-bearish-signals-3740452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MankindPharma_technicaldot_3740452.png",
        "date": "2025-12-02 08:12:59",
        "description": "Mankind Pharma's recent technical indicators reveal a shift in price momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. The stock's performance, combined with key technical signals such as MACD, RSI, and moving averages, provides a nuanced picture of its current market stance amid broader index trends."
      },
      {
        "title": "Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-rise-amid-weak-price-action-3738854",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MankindPharma_oi_spurts_by_underlying_3738854.png",
        "date": "2025-12-01 15:00:10",
        "description": "Mankind Pharma has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid subdued price movement and a broader market environment marked by cautious sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-rise-amid-weak-price-action-3738801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MankindPharma_oi_spurts_by_underlying_3738801.png",
        "date": "2025-12-01 14:00:12",
        "description": "Mankind Pharma has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid a backdrop of subdued price performance and reduced delivery volumes, prompting a closer examination of the underlying market dynamics and potential directional bets."
      },
      {
        "title": "Mankind Pharma Technical Momentum Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-technical-momentum-shifts-amid-bearish-sentiment-3727719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MankindPharma_technicaldot_3727719.png",
        "date": "2025-11-25 08:15:25",
        "description": "Mankind Pharma’s recent technical indicators reveal a nuanced shift in price momentum, reflecting a complex interplay of bearish and bullish signals amid a challenging market backdrop. The stock’s performance contrasts with broader indices, underscoring sector-specific pressures and evolving investor sentiment."
      },
      {
        "title": "Mankind Pharma Sees Notable Surge in Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-bearish-market-signals-3725826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MankindPharma_oi_spurts_by_underlying_3725826.png",
        "date": "2025-11-24 15:01:31",
        "description": "Mankind Pharma has registered a significant rise in open interest in its derivatives segment, signalling a shift in market positioning amid a backdrop of subdued price movement and sector underperformance. This development invites a closer examination of volume patterns, investor sentiment, and potential directional bets shaping the stock’s near-term outlook."
      },
      {
        "title": "Mankind Pharma Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-downgraded-to-sell-by-marketsmojo-amid-technical-and-financial-concerns-3717218",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MankindPharma_mojoScore_3717218.png",
        "date": "2025-11-20 08:21:38",
        "description": "Mankind Pharma, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters. This article analyses the factors influencing the recent revision in the company’s assessment, providing investors with a comprehensive overview of its current standing."
      }
    ],
    "total": 424,
    "sid": "1003845",
    "stock_news_url": "https://www.marketsmojo.com/news/mankind-pharma-1003845"
  },
  "announcements": [
    {
      "caption": "Intimation Regarding ESG Rating",
      "datetime": "10-Dec-2025",
      "details": "Please find attached intimation regard ESG rating",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
      "datetime": "10-Dec-2025",
      "details": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations)",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding ESG Rating",
      "datetime": "28-Nov-2025",
      "details": "Please find attached intimation regarding ESG Rating assigned by SES ESG Research Private Limited.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mankind Pharma Sees Revision in Market Assessment Amidst Valuation and Performance Challenges

2025-12-11 10:10:16

Mankind Pharma's market evaluation has undergone a notable revision, reflecting shifts in its financial and technical outlook. The pharmaceutical company’s recent assessment highlights a complex interplay of valuation concerns, flat financial trends, and subdued technical indicators, set against a backdrop of underwhelming stock returns over the past year.

Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-12-03 15:00:12

Mankind Pharma has experienced a significant rise in open interest in its derivatives segment, signalling a shift in market positioning amid recent price movements and sector trends. This development comes as the stock trades close to its 52-week low, with volume and futures activity reflecting evolving investor sentiment in the Pharmaceuticals & Biotechnology sector.

Is Mankind Pharma technically bullish or bearish?

2025-12-02 09:14:18

Overview of Current Price Action and Trend

Mankind Pharma’s share price currently stands at ₹2,235.40, slightly down from the previous close of ₹2,251.85. The stock has traded within a daily range of ₹2,224.70 to ₹2,271.95, reflecting modest intraday volatility. Over the past 52 weeks, the stock has seen a high of ₹3,050.00 and a low of ₹2,115.50, indicating a significant drawdown from its peak levels.

The technical trend’s recent shift from mildly bearish to bearish signals a deterioration in momentum, suggesting that sellers are gaining control. This change is critical for traders and investors who rely on technical analysis to time their entries and exits.

Technical Indicators: Mixed but Leaning Bearish

Examining the key technical indi...

Mankind Pharma Technical Momentum Shifts Amid Market Challenges

2025-12-02 08:12:59

Mankind Pharma's recent technical indicators reveal a shift in price momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. The stock's performance, combined with key technical signals such as MACD, RSI, and moving averages, provides a nuanced picture of its current market stance amid broader index trends.

Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-12-01 15:00:10

Mankind Pharma has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid subdued price movement and a broader market environment marked by cautious sentiment in the Pharmaceuticals & Biotechnology sector.

Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-12-01 14:00:12

Mankind Pharma has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid a backdrop of subdued price performance and reduced delivery volumes, prompting a closer examination of the underlying market dynamics and potential directional bets.

Mankind Pharma Technical Momentum Shifts Amid Market Challenges

2025-11-25 08:15:25

Mankind Pharma’s recent technical indicators reveal a nuanced shift in price momentum, reflecting a complex interplay of bearish and bullish signals amid a challenging market backdrop. The stock’s performance contrasts with broader indices, underscoring sector-specific pressures and evolving investor sentiment.

Mankind Pharma Sees Notable Surge in Open Interest Amid Market Volatility

2025-11-24 15:01:31

Mankind Pharma has registered a significant rise in open interest in its derivatives segment, signalling a shift in market positioning amid a backdrop of subdued price movement and sector underperformance. This development invites a closer examination of volume patterns, investor sentiment, and potential directional bets shaping the stock’s near-term outlook.

Mankind Pharma Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals

2025-11-20 08:21:38

Mankind Pharma, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters. This article analyses the factors influencing the recent revision in the company’s assessment, providing investors with a comprehensive overview of its current standing.